Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.

G R Matyas1, P H Fishman

  • 1Laboratory of Molecular and Cellular Neurobiology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

Cellular Signalling
|January 1, 1989
PubMed
Summary

Ras oncogenes do not directly impact phospholipid breakdown in NIH/3T3 cells. Elevated diacylglycerol (DAG) levels in ras-transfected cells are independent of phosphoinositide hydrolysis, suggesting ras alters cell growth via non-lipid signaling pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Desensitization of the human D(1) dopamine receptor: Evidence for Involvement of both cyclic AMP-dependent and receptor-specific protein kinases.

Molecular and cellular neurosciences·2009
Same author

beta(1)-Adrenergic and D(1) Dopaminergic Receptors in Human Neurotumor Cells: Differences in Spare Receptors and Desensitization of Adenylyl Cyclase.

Molecular and cellular neurosciences·2009
Same author

Specificity in protein-membrane associations: the interaction of gangliosides with Escherichia coli heat-labile enterotoxin and choleragen.

Biophysical journal·2009
Same author

Protein kinase C-mediated down-regulation of beta(2)-adrenergic receptor and gene expression in rat C6 glioma cells.

Journal of neurochemistry·2001
Same author

Induction and detection of antibodies to squalene.

Journal of immunological methods·2000
Same author

Detection of beta-adrenergic receptors by radioligand binding.

Methods in molecular biology (Clifton, N.J.)·2000

Area of Science:

  • Cellular Biology
  • Oncology
  • Molecular Signaling

Background:

  • Ras oncogenes play a critical role in cellular signaling pathways.
  • Phospholipid breakdown is a key event in signal transduction.
  • Understanding ras oncogene involvement in these pathways is crucial for cancer research.

Purpose of the Study:

  • To investigate the role of ras oncogenes in phospholipid breakdown.
  • To determine the relationship between ras oncogenes, diacylglycerol (DAG) levels, and inositol phosphates.
  • To elucidate the signaling mechanisms by which ras oncogenes affect cell growth.

Main Methods:

  • Culturing untransfected and ras-transfected NIH/3T3 cells at varying densities.
  • Measuring diacylglycerol (DAG) and inositol phosphate levels.

Related Experiment Videos

  • Stimulating cells with serum, bombesin, bradykinin, and aluminum fluoride.
  • Treating cells with dibutyryl cyclic AMP (DB-cAMP).
  • Main Results:

    • Ras-transfected cells exhibited elevated DAG levels at low densities, which decreased at high densities.
    • Mutated ras oncogenes, but not proto-H-ras, led to sustained high DAG levels in transformed cells.
    • Basal inositol phosphate levels were unaffected by ras transfection or cell density.
    • Phosphoinositide hydrolysis was differentially stimulated by various agents depending on ras mutation status.
    • DB-cAMP treatment affected DAG levels but not inositol phosphates, and did not alter basal levels.

    Conclusions:

    • The ras gene product p21 is not directly involved in phosphoinositide hydrolysis.
    • Elevated DAG levels in ras-transfected cells are not a consequence of increased phosphoinositide hydrolysis.
    • DAG levels do not correlate with cell growth in normal or ras-transfected NIH/3T3 cells.
    • Ras appears to alter cell growth through mechanisms independent of lipid signaling pathways, specifically phosphoinositide hydrolysis.